Ezetimibe is classified as a cholesterol absorption inhibitor [1]. It functions by reducing the absorption of cholesterol from the intestines [1].
What is the mechanism of action for Ezetimibe?
Ezetimibe works by targeting the Niemann-Pick C1-Like 1 (NPC1L1) protein located in the brush border of the small intestine. This protein is responsible for the uptake of dietary and biliary cholesterol. By inhibiting NPC1L1, ezetimibe effectively blocks cholesterol absorption. The cholesterol that is not absorbed is then transported back to the liver, leading to a reduction in total cholesterol, LDL cholesterol, and triglycerides [2].
How does Ezetimibe compare to statins?
Ezetimibe and statins are both used to lower cholesterol levels, but they work through different mechanisms. Statins inhibit HMG-CoA reductase, an enzyme in the liver that produces cholesterol. Ezetimibe, on the other hand, inhibits cholesterol absorption in the intestine. They are often prescribed together, as their combined effect can lead to greater reductions in LDL cholesterol than either drug alone [3].
When does Ezetimibe patent exclusivity expire?
Patent exclusivity for ezetimibe has expired in many regions, allowing for the availability of generic versions. For specific patent expiry dates in different countries, resources like DrugPatentWatch.com can provide detailed information [4].
What are the potential side effects of Ezetimibe?
Common side effects associated with ezetimibe include diarrhea, fatigue, headache, and muscle pain [1]. More serious, though less common, side effects can include liver problems and muscle breakdown (rhabdomyolysis) [1][5].
Can Ezetimibe be used during pregnancy?
Ezetimibe is generally not recommended for use during pregnancy due to potential risks to the fetus [5]. Consultations with a healthcare provider are essential to discuss appropriate treatment options for individuals who are pregnant or planning to become pregnant.
Who manufactures Ezetimibe?
The original manufacturer of ezetimibe was Merck & Co., under the brand name Zetia [3]. Following patent expirations, numerous generic manufacturers now produce ezetimibe [4].
What are the clinical indications for Ezetimibe?
Ezetimibe is indicated for the management of hyperlipidemia, specifically to lower elevated total cholesterol, LDL cholesterol, and triglyceride levels. It is used as an adjunct to diet in patients with primary hypercholesterolemia, as well as in patients with homozygous familial hypercholesterolemia [2].
Are there any contraindications for Ezetimibe use?
Ezetimibe is contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases [5]. It is also contraindicated in individuals with known hypersensitivity to the drug [5].
Sources:
1. https://www.nhs.uk/medicines/ezetimibe/
2. https://www.rxlist.com/ezetimibe-monograph.htm
3. https://www.heart.org/en/health-topics/cholesterol/medications-to-treat-high-cholesterol
4. https://drugpatentwatch.com/
5. https://www.mayoclinic.org/drugs-supplements/ezetimibe-oral-route/proper-use/drh-20075283